El uso de corticoides inhalados para el tratamiento de COVID-19 podría disminuir el riesgo de hospitalización o muerte y el tiempo de resolución de síntomas / The use of inhaled corticosteroids for the treatment of COVID-19 may decrease the risk of hospitalisation or death and the time for symptom resolution
Evid. actual. práct. ambul
;
25(1): e007007, 2022. tab
Article
in Spanish
| LILACS, UNISALUD, BINACIS
| ID: biblio-1367741
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Adrenal Cortex Hormones
/
COVID-19
Type of study:
Diagnostic study
/
Etiology study
/
Risk factors
/
Systematic reviews
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Evid. actual. práct. ambul
Year:
2022
Type:
Article
Institution/Affiliation country:
Hospital Italiano de Buenos Aires/AR
Similar
MEDLINE
...
LILACS
LIS